MSBs aGVHD product has only been tested in children. CYP has tested its product in adults and only requires a smaller number of doses compared to MSB.
2020 - A Year Full Of Potentials, page-215
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.025(10.0%) |
Mkt cap ! $49.68M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.0¢ | 26.0¢ | $21.04K | 77.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 157000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 4297 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |